GT Biopharma GTBP
NASDAQ GTBP
$6.20 -0.27 (-4.17%)
At close: Oct 1, 2026 · 4:00 PM EDT

GT Biopharma (GTBP) Long-Term Debt Repayments (2011 - 2019)

Updated

GT Biopharma (GTBP) reported Long-Term Debt Repayments of $100,000 for FY2019, down 97.7% from $4.42 million in FY2018.

Analysis

GT Biopharma (GTBP) Long-Term Debt Repayments (2011 - 2019) Analysis & Trends

Dating back to FY2013, GT Biopharma's Long-Term Debt Repayments record includes 4 years.

  • Long-Term Debt Repayments has a five-year compound annual growth rate of 75.5% (FY2014 to FY2019).
  • The FY2019 figure ranks as the lowest annual Long-Term Debt Repayments since FY2014.
  • According to Business Quant data, Long-Term Debt Repayments came in at $4.42 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 2.00 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.45 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 17.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 GT Biopharma 9.11 Mn 9.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 100,000.00
Dec 31, 2018 -4,000.00
Sep 30, 2018 4.42 Mn
Dec 31, 2014 6,000.00
Dec 31, 2013 -26,000.00
Mar 31, 2013 34,000.00
Dec 31, 2011 -50,000.00
API Access

GT Biopharma Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=GTBP&period=max&api_key=YOUR_API_KEY